Ginkgo Bioworks Holdings Inc
NYSE:DNA
Ginkgo Bioworks Holdings Inc
NYSE:DNA
Price:
0.75 USD
-2.1%
Updated:
May 21, 2024
Balance Sheet
Balance Sheet Decomposition
Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks Holdings Inc
| Current Assets | 903m |
| Cash & Short-Term Investments | 840.4m |
| Receivables | 37.4m |
| Other Current Assets | 25.2m |
| Non-Current Assets | 678.7m |
| Long-Term Investments | 76m |
| PP&E | 416.8m |
| Intangibles | 125.3m |
| Other Non-Current Assets | 60.6m |
| Current Liabilities | 169m |
| Accounts Payable | 27m |
| Accrued Liabilities | 108.4m |
| Other Current Liabilities | 33.6m |
| Non-Current Liabilities | 425.4m |
| Other Non-Current Liabilities | 425.4m |
Balance Sheet
Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks Holdings Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
495
|
381
|
1 550
|
1 316
|
944
|
|
| Cash Equivalents |
495
|
381
|
1 550
|
1 316
|
944
|
|
| Total Receivables |
9
|
24
|
150
|
84
|
32
|
|
| Accounts Receivables |
8
|
22
|
136
|
83
|
18
|
|
| Other Receivables |
1
|
2
|
14
|
2
|
14
|
|
| Inventory |
0
|
3
|
3
|
4
|
0
|
|
| Other Current Assets |
8
|
19
|
20
|
46
|
26
|
|
| Total Current Assets |
512
|
427
|
1 723
|
1 450
|
1 002
|
|
| PP&E Net |
63
|
121
|
146
|
716
|
397
|
|
| PP&E Gross |
63
|
121
|
146
|
716
|
397
|
|
| Accumulated Depreciation |
22
|
34
|
61
|
93
|
121
|
|
| Intangible Assets |
4
|
3
|
22
|
111
|
83
|
|
| Goodwill |
2
|
2
|
21
|
60
|
49
|
|
| Note Receivable |
4
|
13
|
0
|
0
|
14
|
|
| Long-Term Investments |
107
|
103
|
115
|
114
|
79
|
|
| Other Long-Term Assets |
6
|
6
|
44
|
89
|
42
|
|
| Other Assets |
2
|
2
|
21
|
60
|
49
|
|
| Total Assets |
697
N/A
|
675
-3%
|
2 071
+207%
|
2 539
+23%
|
1 665
-34%
|
|
| Liabilities | ||||||
| Accounts Payable |
2
|
14
|
8
|
11
|
9
|
|
| Accrued Liabilities |
14
|
28
|
93
|
115
|
110
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
0
|
0
|
0
|
|
| Other Current Liabilities |
23
|
31
|
33
|
48
|
44
|
|
| Total Current Liabilities |
40
|
73
|
135
|
173
|
164
|
|
| Long-Term Debt |
17
|
17
|
22
|
0
|
0
|
|
| Minority Interest |
9
|
9
|
62
|
0
|
0
|
|
| Other Liabilities |
139
|
115
|
347
|
630
|
404
|
|
| Total Liabilities |
204
N/A
|
214
+5%
|
566
+165%
|
803
+42%
|
568
-29%
|
|
| Equity | ||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
341
|
468
|
2 298
|
4 398
|
5 291
|
|
| Additional Paid In Capital |
834
|
929
|
3 805
|
6 136
|
6 386
|
|
| Other Equity |
0
|
0
|
2
|
3
|
1
|
|
| Total Equity |
493
N/A
|
461
-6%
|
1 505
+226%
|
1 736
+15%
|
1 097
-37%
|
|
| Total Liabilities & Equity |
697
N/A
|
675
-3%
|
2 071
+207%
|
2 539
+23%
|
1 665
-34%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
1 875
|
1 875
|
1 611
|
1 892
|
2 001
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
